Coagulation testing - base year

Ended Purchase Order Awarded Last action

Contract number
W91YTZ20P0211
Awardee
Awarding agency
Obligated
$686,055

Award facts

Opportunity
Contract value 100% obligated
$686,054.81 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Funding agency
Defense Health Agency Department of Defense
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Fort Liberty, NC 28310, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00011 · Coagulation testing decrement -$26,367
Funding Only Action P00010 · VGM umod FY25 funding coagulation testing wamc $142,484
Exercise an Option P00009 · FY25 option W91YTZ20P0211 4OY $0
Funding Only Action P00008 · MOD - coagulation testing FY24 funding $142,484
Exercise an Option P00007 · MOD FY24 OY3 $0
Funding Only Action P00006 · MOD fund FY23 $142,484
Exercise an Option P00005 · MOD - OY2 exercise FY23 SAF coagulation -werfen $0
Other Administrative Action P00004 · MOD- admin part number change $0
Funding Only Action P00003 · MOD FY22 funding for OY1 coagulation supplies $142,484
Exercise an Option P00002 $0
Funding Only Action P00001 $142,484
Original award $0
Show all 12

About this award

The Defense Health Agency awarded Werfen USA LLC a $686,054.81 firm fixed-price purchase order for coagulation testing services and supplies at Fort Liberty, North Carolina. The award, announced on August 17, 2020, follows the Army Medical Command's solicitation for reagents and automated analyzers to support ongoing coagulation testing requirements at the installation. Under the contract, Werfen USA LLC is responsible for providing all necessary personnel, equipment, maintenance, transportation, supplies, training, and related items to perform the required testing services through July 31, 2025. No small business set-aside designation was used for this procurement, allowing Werfen to compete as a full-sized contractor. The contract was awarded without utilizing any special set-aside provisions.

Werfen USA LLC, a Bedford, Massachusetts-based manufacturer of in vitro diagnostic equipment and reagents, is well-positioned to fulfill this requirement given its extensive experience supplying clinical laboratory diagnostic technologies to federal healthcare agencies. The company maintains multiple blanket purchase agreements and indefinite delivery/indefinite quantity contract vehicles with the Department of Veterans Affairs and other federal agencies for similar coagulation testing services and laboratory instrumentation. This purchase order aligns with Werfen's established capabilities in providing coagulation analyzers, testing reagents, and associated consumables to support federal medical operations across various healthcare facilities.

Quick answers

Who was awarded contract W91YTZ20P0211?

W91YTZ20P0211 was awarded to Werfen USA LLC by Medical Command (Department of the Army) on August 17, 2020.

How much is contract W91YTZ20P0211 worth?

The government has obligated $686,055 on W91YTZ20P0211.

Which agency awarded contract W91YTZ20P0211?

Medical Command (Department of the Army) awarded W91YTZ20P0211, with funding from Defense Health Agency (Department of Defense).

Was contract W91YTZ20P0211 competed?

The extent of competition for W91YTZ20P0211 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award